Cedar Brook Financial Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-5,198
| Closed | -$245K | – | 330 |
|
|
2020
Q3 | $245K | Hold |
5,198
| – | – | 0.1% | 236 |
|
|
2020
Q2 | $265K | Buy |
5,198
+36
| +0.7% | +$1.84K | 0.12% | 211 |
|
|
2020
Q1 | $244K | Sell |
5,162
-8
| -0.2% | -$378 | 0.14% | 193 |
|
|
2019
Q4 | $304K | Buy |
5,170
+24
| +0.5% | +$1.41K | 0.13% | 201 |
|
|
2019
Q3 | $275K | Sell |
5,146
-67
| -1% | -$3.58K | 0.12% | 219 |
|
|
2019
Q2 | $261K | Sell |
5,213
-2
| -0% | -$100 | 0.12% | 229 |
|
|
2019
Q1 | $272K | Sell |
5,215
-35
| -0.7% | -$1.83K | 0.13% | 212 |
|
|
2018
Q4 | $251K | Buy |
+5,250
| New | +$251K | 0.15% | 188 |
|